The overall goal in the management of Raynaud’s is to decrease the intensity and severity of attacks and improve the quality of life. Primary Raynaud’s is generally a benign condition which can be managed with non-pharmacological interventions alone in most cases, whereas pharmacotherapy is generally required in most cases of secondary Raynaud’s. Long-acting calcium channel blockers such as amlodipine or nifedipine are the drugs of choice. Other classes of drugs include phosphodiesterase-5 inhibitors, prostacyclin analogs, topical nitrates, etc. Surgical interventions are generally reserved for severe and unresponsive cases.